Featured Research

from universities, journals, and other organizations

Researchers Look To Stem Cell Therapy And Bone Marrow Transplants To Find A Cure For Diabetes

Date:
December 10, 2003
Source:
American Society Of Hematology
Summary:
Millions of Americans are diagnosed with type I diabetes every year. The disease, which results from the body's failure to produce insulin, continues to be a mystery to the medical community, although both genetics and environmental factors appear to play a role in the cause.

San Diego, Calif. (December 8, 2003) -- Millions of Americans are diagnosed with type I diabetes every year. The disease, which results from the body's failure to produce insulin, continues to be a mystery to the medical community, although both genetics and environmental factors appear to play a role in the cause. Type 1 diabetes is usually diagnosed in children or young adults and, if not properly treated, can lead to complications such as heart and kidney disease, stroke, amputations, blindness, and even death. Advancements in research continue to move steadily toward an eventual cure through the use of breakthroughs such as cellular therapy and bone marrow transplantation, as shown by several studies presented during the 45th Annual Meeting of the American Society of Hematology.

"As researchers seek out a possible cure for type 1 diabetes, stem cell therapy and bone marrow transplantation are important avenues of exploration," said Janis Abkowitz, M.D., Head of the Hematology Section, University of Washington Medical Center and Professor of Medicine, University of Washington, Seattle. "Although we have a long way to go, this field shows promise."

Derivation of Functional Insulin Producing Cells From Human Bone Marrow-Derived Stem Cells (Abstract 750)

Insulin dependent type 1 diabetes is an autoimmune disorder, meaning the body's own immune system attacks native cells and tissue because it recognizes the material as foreign matter. In the case of type 1 diabetes, insulin producing beta cells that are found in the pancreas are destroyed by the body's own T-cells, a natural immune response gone haywire. In an attempt to circumvent this troublesome immune response, potential cellular therapies, such as islet (endocrine) cell transplantation, have recently been explored through research. However, even these novel therapies are hampered by islet donor availability, immune rejection, and an inability to replicate the result in multiple animal models.

A study conducted by Lijun Yang, M.D., and researchers at University of Florida used bone marrow-derived stem cells to determine whether or not they could ultimately lead to insulin-producing cells through in vitro (in an artificial environment) trans-differentiation. Recent research has indicated that adult bone marrow is a potential source for cells with pluripotent differentiation capacity, or the ability to give rise to any number of differentiated cell lines.

"Human bone marrow is an ideal source for stem cells because it is readily available and easily secured with a relatively simple procedure," said Dr. Yang. "Also, bone marrow-derived stem cells may not have the same antigen as pancreatic beta cells, which would eliminate the potential for rejection or a negative immune response after cellular implantation."

Results from this study showed that human bone marrow-derived single stem cell lines demonstrated an ability to proliferate and differentiate in vitro. These cells were induced through in vitro culture conditions to differentiate into islet like cells that were capable of glucose-related insulin production, with confirmed expression through RT-PCR (reverse transcription-polymerase chain reaction) of multiple genes known to be related to pancreatic beta cell development and function. Researchers implanted these islet-like cells into the spleen and kidney capsule of an NOD-SCID (non-obese diabetic-streptozotocin-induced diabetic) mouse model with a blood sugar level of 400 mg/dL. They monitored the diabetic mouse's glucose level for up to 56 days and observed an apparent reduction in glucose levels after two weeks.

"Our findings show that human bone marrow-derived stem cells may serve as a potential autologous source for cell therapy in the treatment of patients with type 1 diabetes," said Dr. Yang. "This means that we may one day be able to use a person's own stem cells to reverse their diabetes."

Hematopoietic Stem Cell Transplantation Allows for Tolerance for Allogeneic Islets But Does Not Significantly Contribute to Organ Regeneration (Abstract 746)

Hematopoietic stem cell transplantation is known to cure many disorders such as leukemia and certain cancers, bone marrow failure syndromes, and genetic diseases. The body uses stem cells to replace cells that have been damaged or killed. Recent research examines this still burgeoning bone marrow transplant technology for potential application in the field of diabetes. A study led by Elizabeth Kang, M.D., and researchers at the National Institute of Diabetes and Digestive and Kidney Diseases of the National Institutes of Health sought to determine whether or not bone marrow transplantation and full donor hematopoietic engraftment could give rise to insulin-producing pancreatic islet cells. Results showed that the capacity of hematopoietic cells to regenerate the pancreas, without additional manipulation, was unsuccessful. However, results did show that implanted islet cells seemed well tolerated in mice receiving bone marrow transplants.

Using a NOD (non-obese diabetic) mouse model with naturally occurring autoimmune diabetes, researchers performed bone marrow transplants prior to, at the onset of, and two weeks beyond the development of diabetes. Expected age of diabetes onset in these mice is 12 to 16 weeks. Bone marrow recipients were then monitored for the onset or presence of diabetes. Of the eight mice that were fully engrafted prior to the onset of diabetes, all appeared symptom free beyond one year of follow-up. In contrast, mice that failed to achieve full engraftment of the bone marrow transplant developed or remained diabetic. Those mice that successfully engrafted at or after onset of diabetes also remained hyperglycemic.

To gauge whether or not tolerance to islet cell transplantation was achieved, mice that had undergone successful hematopoietic transplantation, characterized by full engraftment, were injected intraperitoneally (in the abdominal cavity) with a minimum of 300 islet cells obtained from the same allogeneic (of the same species, but genetically different) donor strain as the hematopoietic cells. Results showed two of four mice that had undergone hematopoietic transplantation followed by islet transplantation seemingly experienced a reversion of their diabetes, however the four controls that received islets without prior hematopoietic transplantation remained diabetic.

"The results of this study were negative in that we did not see regeneration of islet cells after bone marrow transplantation alone, but we did confirm tolerance to islet cell grafts," said Dr. Kang. "Without further manipulation, bone marrow transplantation in and of itself will not cure diabetes, but this method still holds promise and could potentially unlock doors leading to future progress in the field of cell therapy-derived cures for diabetes."

###

The American Society of Hematology is the world's largest professional society concerned with the causes and treatment of blood disorders. Its mission is to further the understanding, diagnosis, treatment, and prevention of disorders affecting blood, bone marrow, and the immunologic, hemostatic, and vascular systems, by promoting research, clinical care, education, training, and advocacy in hematology.


Story Source:

The above story is based on materials provided by American Society Of Hematology. Note: Materials may be edited for content and length.


Cite This Page:

American Society Of Hematology. "Researchers Look To Stem Cell Therapy And Bone Marrow Transplants To Find A Cure For Diabetes." ScienceDaily. ScienceDaily, 10 December 2003. <www.sciencedaily.com/releases/2003/12/031210075128.htm>.
American Society Of Hematology. (2003, December 10). Researchers Look To Stem Cell Therapy And Bone Marrow Transplants To Find A Cure For Diabetes. ScienceDaily. Retrieved April 23, 2014 from www.sciencedaily.com/releases/2003/12/031210075128.htm
American Society Of Hematology. "Researchers Look To Stem Cell Therapy And Bone Marrow Transplants To Find A Cure For Diabetes." ScienceDaily. www.sciencedaily.com/releases/2003/12/031210075128.htm (accessed April 23, 2014).

Share This



More Health & Medicine News

Wednesday, April 23, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Big Pharma Braces for M&A Wave

Big Pharma Braces for M&A Wave

Reuters - Business Video Online (Apr. 22, 2014) Big pharma on the move as Novartis boss, Joe Jimenez, tells Reuters about plans to transform his company via an asset exchange with GSK, and Astra Zeneca shares surge on speculation that Pfizer is looking for a takeover. Joanna Partridge reports. Video provided by Reuters
Powered by NewsLook.com
How Smaller Plates And Cutlery Could Make You Feel Fuller

How Smaller Plates And Cutlery Could Make You Feel Fuller

Newsy (Apr. 22, 2014) NBC's "Today" conducted an experiment to see if changing the size of plates and utensils affects the amount individuals eat. Video provided by Newsy
Powered by NewsLook.com
How to Master Motherhood With the Best Work/Life Balance

How to Master Motherhood With the Best Work/Life Balance

TheStreet (Apr. 22, 2014) In the U.S., there are more than 11 million couples trying to conceive at any given time. From helping celebrity moms like Bethanny Frankel to ordinary soon-to-be-moms, TV personality and parenting expert, Rosie Pope, gives you the inside scoop on mastering motherhood. London-born entrepreneur Pope is the creative force behind Rosie Pope Maternity and MomPrep. She explains why being an entrepreneur offers the best life balance for her and tips for all types of moms. Video provided by TheStreet
Powered by NewsLook.com
Catching More Than Fish: Ugandan Town Crippled by AIDS

Catching More Than Fish: Ugandan Town Crippled by AIDS

AFP (Apr. 22, 2014) The village of Kasensero on the shores of Lake Victoria was where HIV-AIDS was first discovered in Uganda. Its transient population of fishermen and sex workers means the nationwide programme to combat the virus has had little impact. Duration: 02:30 Video provided by AFP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins